| INTRODUCTION
Vascularization is essential for tissue growth and homeostasis.
Except for vasculogenesis in early embryonic development, angiogenesis, the outgrowth of new vessels from existing ones, plays a central role in neovascularization under both physiological and pathological conditions, although vasculogenesis has also been suggested in adults in recent years (Adams & Alitalo, 2007) .
Angiogenesis is largely accomplished by the sprouting of endothelial cells (ECs), which involves cell proliferation, differentiation, adhesion, and guided migration (Gerhardt et al., 2003) . Of note, sprouting angiogenesis is triggered by hypoxia and other related stress signals that hold potentials to induce cell death; and remodeling of newly formed vessel plexus requires apoptosis of ECs (Korn & Augustin, 2015; Pugh & Ratcliffe, 2003) . Therefore, appropriate regulation of EC survival and apoptosis is critically involved in angiogenic sprouting, but the underlying molecular mechanisms have not been completely elucidated.
A number of molecules and signaling pathways have been identified in regulating EC behavior during angiogenesis. The initial step of angiogenesis involves activation and differentiation of quiescent ECs into the tip and stalk ECs, which navigate hypoxic tissues by long filopodia and elongate vessel sprouts via proliferation, respectively (Jakobsson et al., 2010) . Tip cells express a high level of vascular endothelial growth factor receptor 2/3 (VEGFR2/3) to sense vascular endothelial growth factor A (VEGFA), the most important angiogenic cytokine (Blanco & Gerhardt, 2013) . On the other hand, stalk cell behavior is suppressed in tip cells by neuropilin 1 (NRP1)-mediated inhibition of bone morphogenetic protein (BMP)-activin receptor-like kinase (ALK) signaling (Aspalter et al., 2015; Fantin et al., 2013) . Roundabout homologue 4 (ROBO4)-uncoordinated 5 homologue B (UNC5B) interaction blocks angiogenesis, and maintains vessel integrity (Koch et al., 2011) . In addition, metabolism serves as one of the elements controlling EC behaviors in sprouting.
It has been shown that 6-phosphofructo-2-kinase/fructose2, 6-bisphosphatase-3 (PFKFB3) enhances glycolysis in tip cells to guarantee the competitive energy supply (De Bock et al., 2013; Schoors et al., 2014) . Carnitine palmitoyltransferase 1a (CPT1a)-controlled fatty acid oxidation regulates nucleotide synthesis and proliferation of ECs in stalk cells (Schoors et al., 2015) . MicroRNAs (miRNAs) are novel angiogenic regulators that modulate gene expression by binding to the 3′-untranslated region (3′-UTR) of messenger RNAs (mRNAs) with seed sequence (Kane, Thrasher, Angelini & Emanueli, 2014; Landskroner-Eiger, Moneke, & Sessa, 2013) . Knockout of Dicer in ECs results in reduced angiogenic response to limb ischemia and vascular endothelial growth factor (VEGF) stimulation (Suarez et al., 2008) . Several miRNAs including miR-126, miR-218, miR-342-5p, among others, have been implicated in angiogenesis (Fish et al., 2008; Small, Sutherland, Rajagopalan, Wang, & Olson, 2010; Yan et al., 2016) .
The Notch signaling pathway represents an evolutionarily highly conserved pathway mediating contact-dependent communications between neighboring cells (Gridley, 2007) . Proper activation of the Notch signal is essential for endothelial sprouting in angiogenesis and maintaining vascular homeostasis (Blanco & Gerhardt, 2013; Hellstrom et al., 2007) . Deficiency of recombination binding protein Jκ (RBP-J), the integrative downstream transcription factor of canonical Notch signaling, leads to excessive sprouting and malformation of vessels, while activation of Notch signaling restricts angiogenesis (Dou et al., 2008 Mice of the C57BL/6 lineage were maintained under specific pathogen-free conditions. Transgenic mice with conditionally activated EC-specific Notch intracellular domain expression (NIC eCA ) and the control (Ctrl), as well as EC-specific RBP-J knockout (RBPj △E ) and control mice, were described previously (Yan et al., 2016) . For intravitreal injection of small interfering RNA (siRNA), pups of postnatal day (P) 3 were anesthetized by incubating on the ice, and intravitreally injected with 6 μg of siRNA in 0.5 μl phosphate-buffered saline (PBS) in one eye and an equal amount of control oligonucleotides on the other side. Retinas were collected on P6 or P7, fixed in 4% paraformaldehyde (PFA) at 4°C overnight, and subjected to immunofluorescence staining as described below (Pitulescu, Schmidt, Benedito, & Adams, 2010) . The siRNA and control were synthesized as in vivo modified STABLE siRNA by RiboBio (Ribobio, Guangzhou, China).
The sequences were as follows (Si-215-1, 5′-CAGGAAGACAUCC AGAUdTdT; Si-215-2, 5′-GCUCAGAUGAGCUGGCUAAdTdT; Si-Ctrl, 5′-UUCUCCGAACGUGUCACGUdTdT). All animal experiments were approved and followed the guidelines issued by the Animal Experiment Administration Committee of the Fourth Military Medical University.
| Cell culture and transfection
Primary human umbilical vein endothelial cells (HUVECs) were isolated by collagenase treatment of human umbilical tissues. Singlecell suspensions were cultured in endothelial cell medium (ECM; ScienCell, San Diego, CA) supplemented with 5% fetal bovine serum (FBS) and endothelial cell growth supplements (ECGS), 100 U/ml penicillin and 100 μg/ml streptomycin in a humidified atmosphere with 5% CO 2 at 37°C. Cells between passages 3 and 5 were used in the experiments. Lewis lung carcinoma (LLC) cells, Hepa1-6 hepatic carcinoma cells, bEND.3 cells (lined murine ECs) were cultured in Dulbecco's modified Eagle's medium (DMEM) routinely. Mouse primary neural stem cells, mesenchymal stem cells, and macrophages were previously preserved in our lab.
HUVECs were transfected with siRNA or the control oligonucleotides at the concentration of 100 nM in a 6-well plate with 5 µl Lipofectamine 2000™ reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The medium was replaced 6 hr later with normal growth medium. The γ-secretase inhibitor (GSI; Alexis Biochemicals, San Diego, CA) was used at the concentrations of 25 μM. For staining with 5-ethynyl-2′-deoxyuridine (EdU), cells were incubated with 50 μM EdU (Ribobio, Guangzhou, China) in the medium for 2 hr, and then fixed with 4% PFA at room temperature for 30 min, followed by staining with Apollo ® 567. Images were captured under a fluorescence microscope (BX51; Olympus, Tokyo, Japan). Lactate dehydrogenase (LDH) in the culture medium was determined using a kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). For whole-mount retina staining, eyes from P7 pups were prefixed for 2 hr in 4% PFA at room temperature. Retinas were dissected and postfixed for 12 hr in 4% PFA at 4°C. Then retinas were permeabilized and blocked in PBS containing 1% BSA and 0.5% Triton X-100
| Immunofluorescence staining
overnight. Samples were incubated with IB4 and anti-TMEM215 in PBS-0.5% Triton X-100 overnight at 4°C, followed by incubation with the secondary antibodies in PBS overnight at 4°C. Each step was followed by three washes in PBS for 10 min. The retinal tissues were then flat mounted on a glass slide under a dissecting microscope and examined under a confocal laser scanning microscope.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) was performed by using the DeadEnd™ Fluorometric TUNEL System (Promega Corporation, Madison, CA) following the manufacturer's instructions. Briefly, samples were fixed with 4%
PFA and permeabilized in 0.3% Triton X-100, and then incubated with the TUNEL reagents containing Cyanine 3 (Cy3)-dUTP at 37°C
for 1 hr. The samples were washed with PBS and counterstained with DAPI and observed under a fluorescence microscope.
| Transmission electron microscopy (TEM)
Cells were fixed in 2.5% glutaraldehyde followed by ferrocyanidereduced osmium tetroxide. After uranyl staining en bloc, cells were embedded in epoxy resin according to standard procedures. Ultrathin sections were made and observed under an electron microscope (LEO 912AB; Omega) equipped with a camera (SiSVeleta; Olympus) and the iTEM software. 
| Lumen formation assay

| Fibrin gel beads sprouting assay
Fibrin beads sprouting assay was conducted using a fibrin beads assay kit (Amersham-Pharmacia Biotech, Piscataway, NJ) as described previously (Yan et al., 2016) . Briefly, HUVECs were incubated with the Cytodex 3 microcarrier beads (Sigma-Aldrich; 400 cells per bead) at 37°C overnight. The beads were then embedded in the fibrinogen (Sigma-Aldrich) containing 0.625 U/ml thrombin (SigmaAldrich) at a density of 100 beads/ml in a 48-well plate, and 0.5 ml of EGM-2 medium (Clonetics, Walkersville, MD) was added with lung fibroblasts (20,000 cells/well). The medium was changed every other day for 2 or 4 days. Images were taken under a microscope (CKX41;
Olympus) with a CCD camera (DP70; Olympus), and sprouting was quantified by measuring the number and length of sprouts.
| Aortic ring culture
Mice were killed and aortae were collected as previous (Baker et al., 2011) | 9527
| Cell migration and adhesion assays
Cell migration was measured by wound healing assay as described. In brief, after siRNA transfection in a 6-well plate, the scratch was created with a pipette tip, and the medium was then replaced by ECM supplemented with 0.5% FBS without ECGS. Wound closure was observed under a microscope (CKX41; Olympus) with a CCD camera (DP70; Olympus) and measured 16 hr after the scratch was made. For cell adhesion assay, 4 × 10 5 HUVECs were seeded in normal growth medium in a 6-well plate precoated with 0.2% gelatin.
The plates were incubated for 5 min and then shaken for 10 s. After washing, adherent cells were fixed with 4% formaldehyde and stained with crystal violet.
| Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was prepared from cells or tissues with the TRIzol reagent 
| Rapid amplification of cDNA ends (RACE)
RNA isolated from mice brain was reverse-transcribed using the SMARTer RACE cDNA Amplification Kit (Clontech Laboratories, Mountain View, CA), followed by two rounds of PCR amplification of cDNA. The first-round PCR was performed using the specific primer 5′-RACE-TMEM215 or 3′-RACE-TMEM215, and the universal primer mix, and the product was diluted and subjected to the second-round PCR using 5′-NEST-RACE-TMEM215 or 3′-NEST-RACE-TMEM215 primers and nest universal primer (NUP). The sequences of the primers are as follows: 5′-RACE-TMEM215, 5′-CAAGGCACTGTAGGCGAGG GAACTGG; 3′-RACE-TMEM215, 5′-GGGGCATAGTTTAGGGAAG TACGGAGAA; 5′-NEST-RACE-TMEM215, 5′-TCAGGCCGCATCTTT CACTCCATCC; 5′-NEST-RACE-TMEM215, 5′-TGCCCCAGGACAGT ATCATCGTTTG.
| Western blot analysis
Cells were lysed in RIPA buffer (Beyotime, Shanghai, China) containing 10 mM phenylmethanesulfonyl fluoride (PMSF). Samples (20 μg total proteins) were separated by SDS-PAGE and blotted onto polyvinylidene fluoride (PVDF) membranes, followed by probing with primary antibodies and HRP-conjugated secondary antibodies. β-actin was used as a loading control. Membranes were developed using an enhanced chemiluminescence (ECL) system (Clinx Science Instruments, Shanghai, China).
| Statistics
Statistical analysis was performed with the Image-Pro Plus 6.0 (Media Cybernetics, MD) and GraphPad Prism 5 (GraphPad Software, CA). All quantitative data were presented as mean ± SEM.
Statistical significance was calculated using unpaired or paired Student's t test. p < 0.05 was considered as significant.
3 | RESULTS
| Characterization of the TMEM215 gene
In an attempt to identify Notch downstream molecules involved in angiogenesis using microarray, we found that the expression of We then examined the expression of TMEM215 in different mouse tissues by RT-PCR. The result showed that the TMEM215 transcript could be readily detected in retina, and brain, and weakly detected in the kidney (Figure 1e, upper) . In purified or lined cells, TMEM215 mRNA was expressed at the highest level in ECs, although it could also be detected in neural stem cells (Figure 1e , lower). These data suggested that TMEM215 could be involved in the regulation of ECs.
| TMEM215 was dynamically expressed in ECs
To investigate the role of TMEM215 in ECs, we examined its expression in ECs isolated from tissues under different conditions.
Retinas were isolated from P3 and P6 pups, and subjected to 
| TMEM215 was required for survival of ECs
To assess the role of TMEM215 in ECs, we used siRNAs to suppress TMEM215 expression in HUVECs, which was confirmed at both RNA and protein levels (Figure 3a,b) . We found that transfection of Our data strongly suggested that TMEM215 participates in angiogenesis by promoting EC survival. Indeed, knockdown of TMEM215 by using a siRNA directly resulted in cell death in ECs with characteristics of both apoptosis and necrosis in vitro, and intravitreal injection of TMEM215 siRNA disturbed angiogenesis with increased apoptosis of ECs during the development of retinal vasculature. Angiogenic process is accomplished by coordinated cellular actions including proliferation, differentiation, guided migration, and quiescence of ECs (Fruttiger, 2007) .
Controlled cell survival and death of ECs are essential for successful neovascularization by angiogenesis. The initial step of sprouting angiogenesis is typically triggered by hypoxia, which leads to the activation of the Hif-1α signaling pathway followed by the expression of a large panel of angiogenesis-related genes (Pugh & Ratcliffe, 2003) .
However, exposure to severe hypoxia leads to the accumulation of p53, which in turn leads to rapid apoptosis of cells (Banasiak & Haddad, 1998) .
Hypoxia can also lead to attenuated generation of ATP, which can trigger an unfolded protein response (UPR) when the structure of proteins in the endoplasmic reticulum (ER) could not be maintained, a process known as ER stress. Continuous or uncompensated ER stress could result in apoptosis through the activation of the PERK-ATF4 axis that leads to the accumulation of the transcription factor CHOP, or the activation of TRAF2-JNK by IRE1a (Binet & Sapieha, 2015) . Moreover, after the outgrowth and full extension of angiogenic sprouts, the newly formed vessels must undergo remodeling to gain efficient tissue perfusion by vessel pruning and regression (Korn & Augustin, 2015) . These processes are essentially mediated by EC apoptosis through different mechanisms such as survival factor withdrawal, metabolic changes, and activation of apoptotic pathways. Our in vitro and in vivo data showed that TMEM215
is required for EC survival because suppression of TMEM215 expression F I G U R E 4 Knockdown of TMEM215 repressed EC angiogenic capacity in vitro. (a) HUVECs were transfected with Si-Ctrl, Si-215-1, or Si-215-2, followed by lumen formation assay. The length of cell cords was measured and compared (n = 7). (b) HUVECs were transfected as in (a). Cell migration and adhesion were examined by scratch assay and matrix-adhesion assay, respectively, (n = 5 for scratch assay and n = 6 for adhesion assay). (c-e) HUVECs were transfected with Si-Ctrl or Si-215-1, and beads-based sprouting assay was performed (c, upper). Average length of sprouting was determined (d) (n = 10). In lower panels of (c), mouse aortic rings were transfected with Si-Ctrl or Si-215-1, and cultured. Average length and number of sprouts were measured (n = 7). (f) HUVECs were transfected with Si-Ctrl or Si-215-1. The expression of the indicated cytokines was measured. Bar = means ± SD; *p < 0.05, **p < 0.01, and ***p < 0.001. EC: endothelial cells; HUVEC: human umbilical vein endothelial cells; N.S., not significant; SD: standard deviation [Color figure can be viewed at wileyonlinelibrary.com] leads to EC apoptosis and necrosis. It will be of significance to investigate the role of TMEM215 in vessel pruning and regression. Moreover, it is noteworthy that with siRNAs used in the current study, we had just reduced the expression level of TMEM215 to one third as compared with the control, but resulting in significant increase in cell death in ECs. This could imply that TMEM215 plays a nonredundant role in an important pathway that regulates EC death. However, more molecular experiments with gene knockout mice is required to demonstrate this opinion.
The molecular mechanism underlying TMEM215-mediated EC survival is currently unknown. TMEM215 is predicted to interact with MAGI-1, a membrane-associated guanylate kinase (MAGUK) with inverted domain organization (Luck et al., 2011) . MAGI-1 is present in adherent and tight junctions of all epithelial cell types. MAGI-1 is important for VE-cadherin-dependent Rap1 activation and the adherens junction formation upon cell-cell contact in ECs (Sakurai et al., 2006) . In apoptosis, MAGI-1 is a target of caspase-mediated cleavage, an impotent step in the disassembly of cell-cell contacts during apoptosis (Gregorc et al., 2007) . Whether 
